Device Trial Radar · NCT07931482
Revitalis - Midface (Cheek Area)
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Nov 4, 2026
Primary completion
Oct 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Croma-Pharma GmbHNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 12, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate the effects and safety of croma revitalis in improving midface (cheek area) skin smoothness
Conditions
- Skin Smoothness
Interventions
Croma revitalisDevice
Croma revitalis is a hyaluronic acid-based injectable gel for soft tissue implantation and intradermal aesthetic use. 1 mL per cheek side per treatment session, distributed across 4 intradermal injection points (0.25 mL each) using a standardized injection technique with a sterile needle at baseline Week 0, Week 3, and Week 6. After week 6 a follow up period until week 30 is performed at week 9, 12, 16, 20, 24 and 30.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Skin Smoothness: Responder status assessed by independent evaluator at siteTime frame: week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Yuvell
Vienna, Austria · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.